Page last updated: 2024-09-04

docetaxel anhydrous and Jaw Diseases

docetaxel anhydrous has been researched along with Jaw Diseases in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujii, K; Fukutomi, T; Hara, K; Mouri, Y; Nakano, S; Nakaoka, T; Yamada, S; Yorozuya, K; Yoshida, M1
Biganzoli, L; Conte, P; DiƩras, V; Glaspy, J; Guarneri, V; Miles, D; Robert, N; Smith, I; Taran, T; Thomssen, C1
Bi, Y; Cao, C; Ehirchiou, D; Gao, Y; Kikuiri, T; Le, A; Shi, S; Zhang, L1
Goodger, NM; Pogrel, MA; Wang, J1

Other Studies

4 other study(ies) available for docetaxel anhydrous and Jaw Diseases

ArticleYear
A case of osteonecrosis of the jaw in a breast cancer patient with bone metastases receiving long-term treatment with bisphosphonates.
    Breast cancer (Tokyo, Japan), 2009, Volume: 16, Issue:2

    Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Diphosphonates; Docetaxel; Female; Humans; Jaw Diseases; Osteonecrosis; Spinal Neoplasms; Taxoids; Tomography, X-Ray Computed; Trastuzumab

2009
Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer.
    Breast cancer research and treatment, 2010, Volume: 122, Issue:1

    Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Breast Neoplasms; Diphosphonates; Docetaxel; Double-Blind Method; Drug Synergism; Female; Genes, erbB-2; Humans; Incidence; Jaw Diseases; Middle Aged; Multicenter Studies as Topic; Neoplasm Metastasis; Oral Hygiene; Osteonecrosis; Paclitaxel; Prospective Studies; Randomized Controlled Trials as Topic; Taxoids; Vinblastine; Vinorelbine

2010
Bisphosphonates cause osteonecrosis of the jaw-like disease in mice.
    The American journal of pathology, 2010, Volume: 177, Issue:1

    Topics: Animals; Antineoplastic Agents; Bone Density Conservation Agents; Bone Remodeling; Dexamethasone; Diphosphonates; Docetaxel; Humans; Imidazoles; Jaw Diseases; Mandible; Mice; Mice, Inbred C57BL; Neovascularization, Physiologic; Osteocytes; Osteonecrosis; Taxoids; Zoledronic Acid

2010
Osteonecrosis of the jaws associated with cancer chemotherapy.
    Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2003, Volume: 61, Issue:9

    Topics: Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Female; Humans; Jaw Diseases; Middle Aged; Osteonecrosis; Paclitaxel; Taxoids

2003